Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Holista Colltech Limited ( (AU:HCT) ) is now available.
Holista Colltech Limited has announced the appointment of Mr. Robert Gemelli and Mr. Sam Yee as Independent Non-Executive Directors, following the resignations of Mr. David Deloub and Ms. Loren King. This strategic change in leadership is expected to bring valuable expertise in biotech commercialization and capital markets, aiding the company in advancing its pipeline and focusing on corporate recovery. The new directors’ diverse backgrounds in various industries are anticipated to strengthen Holista’s board and support its mission to deliver sustainable, science-backed health and wellness solutions.
More about Holista Colltech Limited
Holista Colltech Limited is a Perth-based company listed on the Australian Securities Exchange, specializing in health and wellness solutions. It operates across four core business divisions: Dietary Supplements, Healthy Food Ingredients, Ovine Collagen, and Infection Control Solutions. The company is known for its market-leading nutritional supplements, patented low-GI food ingredients, premium ovine collagen, and all-natural sanitizers, reflecting a commitment to combining nature and science for healthier lifestyles.
Average Trading Volume: 260,300
Technical Sentiment Signal: Buy
Current Market Cap: A$16M
For a thorough assessment of HCT stock, go to TipRanks’ Stock Analysis page.